221 related articles for article (PubMed ID: 21279330)
1. Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.
Erdorf M; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Apr; 383(4):357-72. PubMed ID: 21279330
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
[TBL] [Abstract][Full Text] [Related]
3. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.
Brand CS; Hocker HJ; Gorfe AA; Cavasotto CN; Dessauer CW
J Pharmacol Exp Ther; 2013 Nov; 347(2):265-75. PubMed ID: 24006339
[TBL] [Abstract][Full Text] [Related]
4. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
5. Characterization of mouse heart adenylyl cyclase.
Göttle M; Geduhn J; König B; Gille A; Höcherl K; Seifert R
J Pharmacol Exp Ther; 2009 Jun; 329(3):1156-65. PubMed ID: 19307450
[TBL] [Abstract][Full Text] [Related]
6. Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis.
Héliès-Toussaint C; Aarab L; Gasc JM; Verbavatz JM; Chabardès D
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F185-94. PubMed ID: 10894801
[TBL] [Abstract][Full Text] [Related]
7. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct.
Hoffert JD; Chou CL; Fenton RA; Knepper MA
J Biol Chem; 2005 Apr; 280(14):13624-30. PubMed ID: 15710610
[TBL] [Abstract][Full Text] [Related]
9. Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries.
Jourdan KB; Mason NA; Long L; Philips PG; Wilkins MR; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1359-69. PubMed ID: 11350817
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse.
Strait KA; Stricklett PK; Chapman M; Kohan DE
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F859-67. PubMed ID: 19955190
[TBL] [Abstract][Full Text] [Related]
11. Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout mice.
Braeunig JH; Schweda F; Han PL; Seifert R
PLoS One; 2013; 8(7):e68009. PubMed ID: 23840883
[TBL] [Abstract][Full Text] [Related]
12. MANT-substituted guanine nucleotides: a novel class of potent adenylyl cyclase inhibitors.
Gille A; Seifert R
Life Sci; 2003 Dec; 74(2-3):271-9. PubMed ID: 14607255
[TBL] [Abstract][Full Text] [Related]
13. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.
Rieg T; Tang T; Murray F; Schroth J; Insel PA; Fenton RA; Hammond HK; Vallon V
J Am Soc Nephrol; 2010 Dec; 21(12):2059-68. PubMed ID: 20864687
[TBL] [Abstract][Full Text] [Related]
14. Localization of mRNAs encoding Ca2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content.
Chabardès D; Firsov D; Aarab L; Clabecq A; Bellanger AC; Siaume-Perez S; Elalouf JM
J Biol Chem; 1996 Aug; 271(32):19264-71. PubMed ID: 8702608
[TBL] [Abstract][Full Text] [Related]
15. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.
Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ
Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412
[TBL] [Abstract][Full Text] [Related]
16. Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2'(3')-O-(N-methylanthraniloyl)-guanosine 5'-[gamma-thio]triphosphate.
Rottlaender D; Matthes J; Vatner SF; Seifert R; Herzig S
J Pharmacol Exp Ther; 2007 May; 321(2):608-15. PubMed ID: 17284671
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
[TBL] [Abstract][Full Text] [Related]
18. Altered collecting duct adenylyl cyclase content in collecting duct endothelin-1 knockout mice.
Strait KA; Stricklett PK; Kohan DE
BMC Nephrol; 2007 May; 8():8. PubMed ID: 17521429
[TBL] [Abstract][Full Text] [Related]
19. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains.
Ostrom RS; Liu X; Head BP; Gregorian C; Seasholtz TM; Insel PA
Mol Pharmacol; 2002 Nov; 62(5):983-92. PubMed ID: 12391260
[TBL] [Abstract][Full Text] [Related]
20. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
